Lv5
830 积分 2022-10-24 加入
Structural Basis of Enhanced Crystallizability Induced by a Molecular Chaperone for Antibody Antigen-Binding Fragments
3小时前
待确认
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
4天前
已完结
Myostatin induces autophagy in skeletal muscle in vitro
10天前
已完结
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer
27天前
已完结
Solution structure of human IL-13 and implication for receptor binding11Edited by P. E. Wright
30天前
已完结
Binding characterization of the interleukin-13 signaling complex and development of a ternary time-resolved fluorescence resonance energy transfer assay
1个月前
已完结
Emerging drugs for the treatment of atopic dermatitis: a focus on phase 2 and phase 3 trials
1个月前
已完结
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
1个月前
已完结
INTERLEUKIN-13 INDUCES THYMUS AND ACTIVATION-REGULATED CHEMOKINE (CCL17) IN HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS
2个月前
已完结
Structural Basis of Signaling Blockade by Anti-IL-13 Antibody Lebrikizumab
2个月前
已完结
皖公网安备34019202002308
